Back
Kanghong Pharma Jumps 10% on Trial Approval for Diabetic Eye Drug
Back
Stock News
Themes
Kanghong Pharma Jumps 10% on Trial Approval for Diabetic Eye Drug
Kanghong Pharma Jumps 10% on Trial Approval for Diabetic Eye Drug
Edgen Stock
·
Jan 05 2026, 06:51
Share to
Share to
Copy link
source:
[1] Kanghong Pharmaceutical (002773.SZ): KH631 Eye Injection Approved for Clinical Trial
Recommend
Agriculture ETFs Break Out on Fertilizer Supply Fears
Mar 06 2026, 16:17
Tango Therapeutics Stock Hits Record High on Erasca Cancer Trial Deal
Mar 06 2026, 16:02
Parker-Hannifin Stock Climbs 53% on Aerospace Demand
Mar 06 2026, 16:01
Features
AI Copilot for Stock & Crypto
Price Prediction
Fundraise Tracker
Themes
Crypto Comparison
Home Page
Resources
Tutorial
Gitbook
Team
Aura Insights
Market
US Market
HK Market
Crypto Market
Terms of Use
Privacy Policy
Sitemap
© 2026 Finture Development Limited. All rights reserved
Edgen Stock·Jan 05 2026, 06:51Edgen Stock·Jan 05 2026, 06:51
Edgen Stock·Jan 05 2026, 06:51